Methimazole (patient information)

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Methimazole)
Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Drug information courtesy of the

Please visit the NLM website for the most current information.

WikiDoc Resources for

Methimazole (patient information)

Articles

Most recent articles on Methimazole (patient information)

Most cited articles on Methimazole (patient information)

Review articles on Methimazole (patient information)

Articles on Methimazole (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Methimazole (patient information)

Images of Methimazole (patient information)

Photos of Methimazole (patient information)

Podcasts & MP3s on Methimazole (patient information)

Videos on Methimazole (patient information)

Evidence Based Medicine

Cochrane Collaboration on Methimazole (patient information)

Bandolier on Methimazole (patient information)

TRIP on Methimazole (patient information)

Clinical Trials

Ongoing Trials on Methimazole (patient information) at Clinical Trials.gov

Trial results on Methimazole (patient information)

Clinical Trials on Methimazole (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Methimazole (patient information)

NICE Guidance on Methimazole (patient information)

NHS PRODIGY Guidance

FDA on Methimazole (patient information)

CDC on Methimazole (patient information)

Books

Books on Methimazole (patient information)

News

Methimazole (patient information) in the news

Be alerted to news on Methimazole (patient information)

News trends on Methimazole (patient information)

Commentary

Blogs on Methimazole (patient information)

Definitions

Definitions of Methimazole (patient information)

Patient Resources / Community

Patient resources on Methimazole (patient information)

Discussion groups on Methimazole (patient information)

Patient Handouts on Methimazole (patient information)

Directions to Hospitals Treating Methimazole (patient information)

Risk calculators and risk factors for Methimazole (patient information)

Healthcare Provider Resources

Symptoms of Methimazole (patient information)

Causes & Risk Factors for Methimazole (patient information)

Diagnostic studies for Methimazole (patient information)

Treatment of Methimazole (patient information)

Continuing Medical Education (CME)

CME Programs on Methimazole (patient information)

International

Methimazole (patient information) en Espanol

Methimazole (patient information) en Francais

Business

Methimazole (patient information) in the Marketplace

Patents on Methimazole (patient information)

Experimental / Informatics

List of terms related to Methimazole (patient information)

Why this medication is prescribed

Methimazole is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It is also taken before thyroid surgery or radioactive iodine therapy.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

How this medication should be used

Methimazole comes as a tablet and usually is taken three times a day, approximately every 8 hours, with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand.

Special precautions

Before taking methimazole:

  • tell your doctor and pharmacist if you are allergic to methimazol, lactose, or any other drugs.
  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially anticoagulants ('blood thinners') such as warfarin (Coumadin), beta blockers such as propranolol (Inderal), diabetes medications, digoxin (Lanoxin), theophylline (Theobid, Theo-Dur), and vitamins.
  • tell your doctor if you have or have ever had any blood disease, such as decreased white blood cells (leukopenia), decreased platelets (thrombocytopenia), or aplastic anemia, or liver disease (hepatitis, jaundice).
  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. Methimazole should not be used during pregnancy or breast-feeding. If you become pregnant while taking methimazole, call your doctor immediately. Methimazole may harm the fetus.
  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking methimazole.

Special dietary instructions

Methimazole may cause an upset stomach. Take methimazole with food or milk.

What to do if you forget a dose

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule at evenly spaced, 8-hour intervals. Do not take a double dose to make up for a missed one.

Side effects

Minor side effects

Methimazole may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • skin rash
  • itching
  • abnormal hair loss
  • upset stomach
  • vomiting
  • loss of taste
  • abnormal sensations (tingling, prickling, burning, tightness, and pulling)
  • swelling
  • joint and muscle pain
  • drowsiness
  • dizziness
  • decreased white blood cells
  • decreased platelets

Severe side effects

If you experience any of the following symptoms, call your doctor immediately:

  • sore throat
  • fever
  • headache
  • chills
  • unusual bleeding or bruising
  • right-sided abdominal pain with decreased appetite
  • yellowing of the skin or eyes
  • skin eruptions

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].

Storage conditions needed for this medication

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Other information

Keep all appointments with your doctor and the laboratory.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

Brand names

  • Tapazole®



WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .